Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Machine learning start-up insitro closes Series A round; over $100mm raised

Executive Summary

Insitro has emerged from stealth mode and announced an impressive syndicate of investors--Arch Venture Partners, Foresite Capital, a16z, GV (formerly Google Ventures), and Third Rock Ventures--who participated in an undisclosed Series A round for the company. Daphne Koller, insitro's founder and CEO, tells industry sources that the firm will collect large data sets to train machine learning models for integration into the drug discovery process.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies